How we chose this list
Each glp-1 telehealth (women) brand on this list was scored against a public 8-axis editorial rubric. Weights and thresholds are published; rankings update quarterly or when and brand makes and material change.
- Clinical credentials of prescribers (board certification + state licensure verification)
- FDA-approved vs compounded medication formulary
- Pricing transparency and insurance acceptance breadth
- Independent patient reviews from ≥2 platforms (filtered for authenticity)
- State availability + telehealth law compliance
Why: All prescribers hold ABOM certification. Insurance-first model. FDA-only formulary.
Best for: Insured women with BMI ≥30 wanting specialist obesity care.
Why: Weight-inclusive care + GLP-1 in and primary-care home.
Best for: Women wanting integrated metabolic care, not GLP-1 alone.
Why: Physician-only prescribing. Broad insurance acceptance.
Best for: Insured patients wanting MD-led primary-care + GLP-1.
Why: Added GLP-1 in Q3 2025 for midlife women. NAMS team.
Best for: Peri/menopausal women with weight gain.
Why: HRT + GLP-1 combo for post-menopausal weight management.
Best for: Post-menopause women combining HRT + GLP-1.
Estimate your cost
Pricing varies dramatically by treatment path and insurance status.
Frequently asked
Why is ABOM certification meaningful?
The American Board of Obesity Medicine (~7,000 certified physicians in US as of 2026) credentials clinicians specifically in obesity medicine. ABOM-credentialed prescribers handle GLP-1 protocols, side effects, a dose titration with deeper training than general primary care.
Is compounded GLP-1 safe?
Compounded semaglutide and tirzepatide are not FDA-reviewed for potency. FDA flagged quality concerns in 2024-2025. Brands ranked here that exclude compounded options (Form Health, Knownwell) are safer-default choices, particularly during the 2026 supply-chain transition period.
Will insurance cover GLP-1 for weight loss?
Some commercial plans cover Wegovy or Zepbound when BMI ≥30, or ≥27 with a comorbidity. Medicare currently does not cover GLP-1 for weight loss alone. The platforms ranked here with insurance expertise handle prior auth and appeals.
Other rankings
References
Regulatory + federal
- FDA. Medications containing semaglutide marketed for type 2 diabetes or weight loss. View source ↗ (accessed 2026-06-01)
Professional society guidelines
- American Board of Obesity Medicine. Diplomate directory. View source ↗ (accessed 2026-06-01)
Peer-reviewed research
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. View source ↗ (accessed 2026-06-01)
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. View source ↗ (accessed 2026-06-01)
Was this Best GLP-1 telehealth (women) ranking helpful?